Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare genetic primary lymphedema characterized by unilateral or bilateral lower limb lymphedema of variable severity. The condition shows almost complete penetrance with onset in childhood or adolescence in females, whereas in males it shows incomplete penetrance with later onset of disease. Lymphoscintigraphy in more severely affected individuals reveals lymphatic abnormalities consistent with lymphangiectasia, valve dysfunction, and thoracic duct reflux.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for CELSR1-related late-onset primary lymphedema.
4 publications have been identified in PubMed for CELSR1-related late-onset primary lymphedema. Research spans Review / Meta-Analysis (50%), Case Report / Case Series (25%), and Basic Science / Preclinical (25%).
Bonardi CM (2026). [PMID: 41530147](https://pubmed.ncbi.nlm.nih.gov/41530147/). *Nat Commun*. [Basic Science / Preclinical]
Chen J (2025). [PMID: 40678385](https://pubmed.ncbi.nlm.nih.gov/40678385/). *Front Genet*. [Case Report / Case Series]
Brenner E (2025). [PMID: 41439975](https://pubmed.ncbi.nlm.nih.gov/41439975/). *Cells*. [Review / Meta-Analysis]
Lee SO (2024). [PMID: 39045461](https://pubmed.ncbi.nlm.nih.gov/39045461/). *Front Cell Dev Biol*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 2:55 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about CELSR1-related late-onset primary lymphedema
AI-curated news mentioning CELSR1-related late-onset primary lymphedema
Updated May 26, 2026
A comprehensive analysis reveals significant histological and molecular alterations in primary lymphedema, providing insights into lymphatic reconstruction outcomes. This study enhances understanding of the disease's pathophysiology, which may inform future therapeutic strategies.